Dietary fat and colon cancer: Modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis

Cancer Research

Volumn 57, Issue 16, 1997, Pages 3465-3470

  Singh, Jagveer ^a   Hamid, Rachid ^a   Reddy, Bandaru S ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; CORN OIL; CYCLOOXYGENASE 2; FAT; FISH OIL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON CANCER; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; FAT INTAKE; FATTY ACID METABOLISM; GENE EXPRESSION; LIPID COMPOSITION; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT; RISK FACTOR;

ANIMALS; AZOXYMETHANE; BODY WEIGHT; CARCINOGENS; COLONIC NEOPLASMS; CORN OIL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FISH OILS; INTESTINAL MUCOSA; ISOENZYMES; MALE; MEMBRANE PROTEINS; NEOPLASM PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, INBRED F344;

EID: 0030817945     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1997. CA-A Cancer J. Clin., 47: 5-27, 1997.
2. Wynder, E. L., Reddy, B. S., and Weisburger, J. H. Environmental dietary factors in colorectal cancer: some unresolved issues. Cancer (Phila.), 70 (Suppl. 5): 1222-1228, 1992.
3. Ames, B. N., Gold, L. S., and Willett, W. C. The causes and prevention of cancer. Proc. Natl. Acad. Sci. USA, 92: 5258-5265, 1995.
4. Giovannucci, E., and Willett, W. C. Dietary factors and risk of colon cancer. Ann. Med., 26: 443-452, 1994.
5. Reddy, B. S. Dietary lipids and colon cancer. In: G. A. Spiller (ed.), Handbook of Lipids in Human Nutrition, pp. 129-134. Boca Raton, FL: CRC Press, Inc., 1996.
6. Caygill, C. P. J., Charlett, A., and Hill, M. J. Fat, fish, fish oil and cancer. Br. J. Cancer, 74: 159-164, 1996.
7. Reddy, B. S. Chemoprevention of colon cancer by dietary fatty acids. Cancer Metastasis Rev., 13: 285-302, 1994.
8. Torosian, M. H., Charland, S. L., and Lippin, J. A. Differential effects of omega-3 and omega-6 fatty acids on primary tumor growth and metastasis. Int. J. Oncol., 7: 667-672, 1995.
9. Hendrickse, C. W., Keighler, M. R. B., and Neoptolemos, J. P. Dietary omega-3 fats reduce proliferation and tumor yields at colorectal anastomosis in rats. Gastroenterology, 109: 431-439, 1995.
10. Lindner, M. A. A fish diet inhibits colon cancer in mice. Nutr. Cancer, 15: 1-11, 1991.
11. Kremer, J. M., Jubiz, M. A., Rynes, R. J., Bartholomew, L. E., Bigaouette, J., Timchalk, M., Beeler, D., and Lininger, L. Fish oil fatty acid supplementation in active rheumatoid arthritis: a double-blind, controlled, crossover study. Ann. Intern. Med., 106: 497-503, 1987.
12. Bittiner, S. B., Tucker, W. F., Cartwight, I., and Bleehan, S. S. A double-blind, randomized, placebo-controlled trial of fish oil in psoriasis. Lancet, 1: 378-380, 1988.
13. Dyerberg, J., Bang, H. O., Stoffersen, E., Moncada, S., and Vane, J. R. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis. Lancet, 2: 117-119, 1978.
14. Dolecek, T. A., and Granditis, G. Dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial (MRFIT). World Rev. Nutr. Diet. 66: 205-216, 1991.
15. Mascioli, E. A., Iwasz, Y., and Trimbos, S. Endotoxin challenge after Menhaden oil diet: effect on survival of guinea pigs. Am. J. Clin. Nutr., 49: 277-282, 1989.
16. Thun, M. J., Namboodiri, M. M., and Heath, C. W., Jr. Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med., 325: 1593-1596, 1991.
17. Giovannucci, E., Egan, K. M., Hunter, D. J., Stampfer, M. J., Colditz, G. A., Willett, W. C., and Speizer, F. E. Aspirin and the risk of colorectal cancer in women. N. Engl. J. Med., 333: 609-614, 1995.
18. Muscat, J. E., Stellman, S. D., and Wynder, E. L. Nonsteroidal antiinflammatory drugs and colorectal cancer. Cancer (Phila.), 74: 1847-1854, 1994.
19. Pelag, I. I., Maibach, H. T., Brown, S. H., and Wilcox, C. M. Aspirin and nonsteroidal antiinflammatory drug use and the risk of subsequent colorectal cancer. Arch. Intern. Med., 154: 349-399, 1994.
20. Waddell, W. R., Gasner, G. F., Cerise, E., J., and Loughry, R. W. Sulindac for polyposis of the colon. Am. J. Surg., 157: 175-178, 1989.
21. Giardiello, G. M., Hamilton, S. R., Krush, A. J., Piantodosi, S., Hylind, L. M., Celano, P., Booker, S. V., Robinson, C. R., and Offerhaus, G. J. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis, N. Engl. J. Med., 328: 1313-1316, 1993.
22. Rao, C. V., Rivenson, A., Simi, B., Zang, E., Kelloff, G., Steele, V., and Reddy, B. S. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res., 55: 1464-1472, 1995.
23. Eberhart, C. E., and Dubois, R. N. Eicosanoids and the gastrointestinal tract. Gastroenterology, 109: 285-301, 1995.
24. Marnett, L. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res., 52: 5575-5589, 1992.
25. Loll, P. J., and Garavito, R. M. The isoforms of cyclooxygenases. Structure and function. Expert Opin. Invest. Drugs, 3: 1171-1180, 1994.
26. Kargman, S. L., O'Neill, G. P., Vickers, P. J., Evans, J. F., Mancini, J. A., and Jothy, S. Expression of prostaglandin G/H-1 and -2 protein in human colon cancer. Cancer Res., 55: 2556-2559, 1995.
27. Sano, H., Kawahito, Y., Wilder, R. L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M., and Hla, T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res., 55: 3785-3789, 1995.
28. Boolbol, S. K., Dannenberg, A. J., Chadburn, A., Martucci, C., Guo, X-J., Ramonetti, J., Abreu-Goris, M., Newmark, H. L., Lipkin, M. L., DeCosse, J., and Bertagnolli, M. M. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res., 56: 2556-2560, 1996.
29. Reddy, B. S., Rao, C. V., and Seibert, K. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res., 56: 4566-4569, 1996.
30. Corey, E. J., Chih, C., and Cashman, J. R. Docosahexacnoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc. Natl. Acad. Sci. USA, 80: 3581-3584, 1984.
31. Hiller, K., Jewell, R., Dorrell, L., and Smith, C. L. Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and their effect upon eicosanoid synthesis in inflammatory bowel disease. Gut, 32: 1151-1155, 1991.
32. Reddy, B. S., and Sugie, S. Effect of different levels of omega-3 and omega-6 fatty acids on azoxymethane-induced colon carcinogenesis in F344 rats. Cancer Res., 48: 6642-6647, 1988.
33. 4. Nature (Lond.), 227: 680-685, 1970.
34. Towbin, H., Stachelin, T., and Gordon, J. Electrophoretic transfer of proteins from polyacryl amide gels to nitrocellulose sheets: procedures and some applications. Proc. Natl. Acad. Sci. USA, 76: 4350-4354, 1979.
35. Otto, J. C., Dewitt, D. L. S., and Smith, W. L. N-Glycosylation of prostaglandin endoperoxide synthase-1 and -2 and their orientation in the endoplasmic reticulum. J. Biol. Chem., 268: 18234-18242, 1993.
36. Kulkarni, N., Zang, E., Kelloff, G., and Reddy, B. S. Effect of chemopreventive agents piroxicam and D,L-a-difluoramethylomithine on intermediate biomarkers of colon carcinogenesis. Carcinogenesis (Lond.), 13: 995-1000, 1992.
37. Rigas, B., Goldman, I. S., and Levine, L. Altered eicosanoid levels in human colon cancer. J. Lab. Clin. Med., 122: 518-523, 1993.
38. Morham, S. G., Langenbach, R., Loftin, C. D., Tiano, H. F., Vouloumanos, N., Jennette, J. C., Mahler, J. F., Kluckman, K. D., Ledford, A., Lee, C. A., and Smithies, O. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell, 83: 473-482, 1995.
39. Langenbach, R., Morham, S. G., Tiano, H. F., Loftin, C. D., Ghanayem, B. I., Chulada, P. C., Mahler, J. F., Lee, C. A., Goulding, E. H., Kluckman, K. D., Kim, H. S., and Smithies, O. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell, 83: 483-492, 1995.
40. Herschman, H. R. Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Metastasis Rev., 13: 241-256, 1994.
41. DeWitt, D., and Smith, W. L. Yes, but do they siill get headaches? Cell. 83: 345-348, 1995.
42. Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S., and Dubois, R. N. Upregulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107: 1183-1188, 1994.
43. Dubois, R. N., Radhika, A., Reddy, B. S., and Entingh, A. J. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology. 110: 1259-1262, 1996.
44. Morita, I., Schindler, M., Regier, M. K., Otto, J. C., Hori, T., DeWitt, D. L., and Smith, W. L. Different intracellular locations for prostaglandin endoperoxidase H synthase-1 and -2. J. Biol. Chem., 270: 10902-10908, 1995.
45. Barrow, B. J., Ortiz-Reyes, R., O'Riordan, M. A., Stellato, T. A., and Pretlow, T. P. Enzymealtered foci in colons of carcinogen-treated rats. Cancer Res., 50: 1911-1916, 1990.
46. Good, C. K., Adam, J., Lasko, C. M., and Bird, R. P. Dietary lipids affect different stages of the multi-step process of colon carcinogenesis. Proc. Am. Assoc. Cancer Res., 38: 113, 1997.
47. Smith, B. J., Curtis, J. F., and Eling, T. E. Bioactivation of xenobiotics by prostaglandin H synthetase. Chem.-Biol. Interact., 79: 245-264, 1991.
48. Kutchera, W., Jones, D. A., Matsunami, N., Groden, J., McIntyre, T. M. Zimmerman, G. A., White, R. L., and Prescott, S. M. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc. Natl. Acad. Sci. USA, 93: 4816-4820, 1996.
49. Prescott, S. M., and White, R. L. Self promotion? Intimate connections between APC and prostaglandin H synthase-2. Cell. 87: 783-786, 1996.